<?xml version="1.0" encoding="UTF-8" standalone="yes"?><sourceSummaryOutput><SourceId>1250587</SourceId><Description>Clinical Trial Registry</Description><Title>NCT00635596: Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer (MT110-101)</Title><Origin>Micromet GmbH</Origin><PublicationDetails><Year>2008</Year></PublicationDetails></sourceSummaryOutput>